Previous 10 | Next 10 |
Financials for First Quarter of Fiscal Year 2021 ended June 30, 2020 will be released August 14, 2020 NORTHVALE, NJ / ACCESSWIRE / August 14, 2020 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing and manufacturing niche...
Financials for First Quarter of Fiscal Year 2021 ended June 30, 2020 will be released August 14, 2020 NORTHVALE, NJ / ACCESSWIRE / August 12, 2020 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing niche generic products,...
Elite Pharmaceuticals, Inc. (ELTP) Q4 2020 Earnings Conference Call June 30, 2020 11:30 AM ET Company Participants Nasrat Hakim - President and Chief Executive Officer Carter Ward - Chief Financial Officer Conference Call Participants Presentation Operator Good morni...
Conference Call Scheduled for Tuesday, June 30th at 11:30 AM EDT NORTHVALE, NJ / ACCESSWIRE / June 29, 2020 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing niche generic products, announced results for the fiscal year ...
Financials for Fiscal Year Ended March 31, 2020 will be released June 29, 2020 NORTHVALE, NJ / ACCESSWIRE / June 24, 2020 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing niche generic products, announced today that its...
NORTHVALE, NJ / ACCESSWIRE / March 31, 2020 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP) a specialty pharmaceutical company developing niche generic products, announced today that marketing partner Lannett Company, Inc. ("Lannett"), has commenced product launch of El...
Elite Pharmaceuticals, Inc. (ELTP) Q3 2020 Earnings Conference Call February 11, 2020, 11:00 ET Company Participants Nasrat Hakim - Chairman, CEO & President Carter Ward - CFO, Secretary & Treasurer Conference Call Participants Presentation Operator Good morni...
Conference Call Scheduled for Tuesday, February 11th at 11:00 AM EST NORTHVALE, NJ / ACCESSWIRE / February 10, 2020 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing niche generic products, announced results for the third...
Financials for Third Quarter Fiscal Year 2020 Ended December 31, 2020 will be released February 10, 2020 NORTHVALE, NJ / ACCESSWIRE / February 6, 2020 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing niche generic pro...
Having once traded on the AMEX at $20 per share and viewed as an innovative company with a novel technology designed to aid in developing controlled release and abuse-resistant opioids, the competitive environment dramatically changed for Elite Pharma ( ELTP ). Ultimately, their share price dr...
News, Short Squeeze, Breakout and More Instantly...
Elite Pharmaceuticals Inc. Company Name:
ELTP Stock Symbol:
OTCMKTS Market:
Elite Pharmaceuticals Inc. Website:
Financials for Fiscal Year 2024 Ended March 31, 2024 will be released on July 1, 2024 Northvale, New Jersey--(Newsfile Corp. - June 26, 2024) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company developing niche generic products, announced to...